During the past decade, Budai Irgalmasrendi Korhaz conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 16 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 13 clinical trials were completed. i.e. 81.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Budai Irgalmasrendi Korhaz" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Bayer" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Pfizer" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Budai Irgalmasrendi Korhaz" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator and "Advanced Clinical, LLC" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Budai Irgalmasrendi Korhaz" are "Rheumatoid Arthritis" (7 trials), "Arthritis, Psoriatic" (3 trials), "Heart Failure" (3 trials), "Systemic Lupus Erythematosus" (3 trials) and "Acute Myocardial Infarction" (2 trials). Many other conditions were trialed in "Budai Irgalmasrendi Korhaz" in a lesser frequency.

Most popular intervention types in "Budai Irgalmasrendi Korhaz" are "Drug" (33 trials), "Other" (6 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Baricitinib" (2 trials), "Empagliflozin" (2 trials), "Guselkumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Budai Irgalmasrendi Korhaz" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Budai Irgalmasrendi Korhaz". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Budai Irgalmasrendi Korhaz, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Budai Irgalmasrendi Korhaz, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Budai Irgalmasrendi Korhaz has several departments that took part in Clinical trials: "Budai Irgalmasrendi Kórház KHT. II. Reumatológia" - 3 trials